Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    An update to the page revision from v3.6.2 to v3.6.3 was applied, signaling a new version of the page. This change records a version bump rather than a modification to the trial content.
    Difference
    0.1%
    Check dated 2026-07-07T02:40:11.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This indicates a platform or content update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:44:59.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment status as No longer looking for participants. The Intervention/Treatment label is standardized (replacing Intervention / Treatment) and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:36:53.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page's revision history now includes a new entry 'Revision: v3.5.5' and removes the previous 'Revision: v3.5.4' entry. This update represents a minor administrative change to the page metadata rather than user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-06-08T04:30:25.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    This page now shows Revision: v3.5.4, replacing the previous v3.5.3 revision. This indicates a small update to the page record without altering the study details or required actions for participants.
    Difference
    0.1%
    Check dated 2026-05-17T10:46:41.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.